ScholarIQanswers from OpenAlex

A new class of α-ketoamide derivatives with potent anticancer and anti-SARS-CoV-2 activities

PaperCitations, authors & open-access status

A new class of α-ketoamide derivatives with potent anticancer and anti-SARS-CoV-2 activities is a paper indexed in ScholarIQ from OpenAlex.

How many citations does A new class of α-ketoamide derivatives with potent anticancer and anti-SARS-CoV-2 activities have?

ScholarIQcitation count

A new class of α-ketoamide derivatives with potent anticancer and anti-SARS-CoV-2 activities has 29 citations in the OpenAlex counts ScholarIQ stores.

When was A new class of α-ketoamide derivatives with potent anticancer and anti-SARS-CoV-2 activities published?

ScholarIQyear

A new class of α-ketoamide derivatives with potent anticancer and anti-SARS-CoV-2 activities has 2021 year in the ScholarIQ index.

What is the open-access status of A new class of α-ketoamide derivatives with potent anticancer and anti-SARS-CoV-2 activities?

ScholarIQoa status

A new class of α-ketoamide derivatives with potent anticancer and anti-SARS-CoV-2 activities has green oa status in the ScholarIQ index.

What is the DOI of A new class of α-ketoamide derivatives with potent anticancer and anti-SARS-CoV-2 activities?

ScholarIQdoi

The DOI for A new class of α-ketoamide derivatives with potent anticancer and anti-SARS-CoV-2 activities is on the source record.

What is the PMID of A new class of α-ketoamide derivatives with potent anticancer and anti-SARS-CoV-2 activities?

ScholarIQpmid

The PMID for A new class of α-ketoamide derivatives with potent anticancer and anti-SARS-CoV-2 activities is on the source record.

What is the OpenAlex record for A new class of α-ketoamide derivatives with potent anticancer and anti-SARS-CoV-2 activities?

ScholarIQopenalex

The OpenAlex for A new class of α-ketoamide derivatives with potent anticancer and anti-SARS-CoV-2 activities is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial